Oncology

Oncology Practice Software

Infusion scheduling optimization for chemotherapy and immunotherapy. Symptom tracking between treatments through the clinIQ app. Pre-authorization for cancer therapies. Coordination with surgical oncology, radiation oncology, and supportive care.

Infusionscheduling optimization
Symptomtracking included
Multi-specialtycoordination

The Oncology Operations Model

Oncology practices manage cancer treatment through chemotherapy, immunotherapy, targeted therapy, and supportive care. Infusion scheduling drives much of practice operations with treatments lasting hours and requiring chair time coordination. Between-treatment symptom monitoring enables early intervention for complications.

Scheduling complexity spans infusion chairs, physician visits, and lab work that must sequence appropriately. Labs precede physician review that precedes treatment. Infusion duration varies by regimen. Chair utilization determines practice capacity.

Symptom tracking between treatments through the clinIQ app captures side effects, functional status, and concerning symptoms. Early identification of febrile neutropenia, severe nausea, or other complications enables intervention before hospitalization.

Pre-authorization for cancer therapies can be extensive. Expensive regimens require authorization demonstrating medical necessity, appropriate diagnosis, and in some cases genetic testing results.

Care coordination spans surgical oncology, radiation oncology, palliative care, and supportive services. Cancer treatment is inherently multidisciplinary.

Infusion Scheduling Optimization

Scheduling for infusion optimizes chair utilization while accommodating varied treatment durations.

Regimen-based scheduling uses templates for common regimens specifying expected duration. A short infusion differs from all-day chemotherapy in chair requirements. Scheduling templates account for these differences.

Chair utilization tracking shows how effectively infusion chairs are used. Empty chairs during operating hours represent lost capacity. Analytics reveal utilization patterns and optimization opportunities.

Lab sequencing ensures blood work is completed and reviewed before treatment. Patients arrive for labs, then see the physician, then proceed to infusion. Patient flow tracks this sequence.

Physician review timing between labs and infusion allows treatment plan confirmation or modification. Flow must allow adequate review time.

Pre-medication timing for regimens requiring anti-emetics or other pre-medications schedules appropriately before chemotherapy.

Patient self-scheduling through the patient app works for non-infusion visits while infusion scheduling remains staff-managed given regimen complexity.

Symptom Tracking Between Treatments

Symptom tracking through the clinIQ app captures treatment side effects and enables early intervention.

Side effect monitoring captures nausea, fatigue, neuropathy, and other common chemotherapy effects. Severity ratings over time show treatment tolerance. Escalating symptoms may require supportive care adjustment or treatment modification.

Temperature and infection symptom tracking enables early identification of febrile neutropenia. Patients reporting fever trigger urgent outreach through secure messaging or phone.

Functional status tracking shows how patients are managing daily activities. Declining function may indicate treatment toxicity or disease progression.

Pain tracking documents cancer pain and response to pain management. Patterns inform analgesic adjustment.

Nutrition and weight tracking monitors for cancer cachexia and nutritional compromise. Weight trends visible over treatment course.

Wearable integration captures activity levels showing functional capacity. Declining activity may precede reported symptom changes.

Prior Authorization for Cancer Therapies

Pre-authorization for cancer therapies addresses expensive treatments requiring payer approval.

Chemotherapy authorization documents diagnosis, staging, and treatment plan appropriateness. Prior treatment history for second-line and subsequent regimens must demonstrate progression or intolerance.

Immunotherapy authorization may require PD-L1 testing, MSI status, or other biomarkers demonstrating likely benefit.

Targeted therapy authorization requires genetic testing results showing actionable mutations matching the therapy.

Supportive care authorization for colony-stimulating factors, anti-emetics, and other supportive medications addresses indication and necessity.

Authorization tracking through pre-authorization shows status for each patient's treatments. Expirations alert before treatment interruption.

Analytics reveal approval rates, denial reasons, and turnaround times by payer and therapy type.

Multi-Specialty Care Coordination

Oncology requires coordination with specialists managing different aspects of cancer care.

Surgical oncology coordination for tumor resection involves treatment sequencing with neoadjuvant and adjuvant therapy. Secure messaging and file exchange communicate treatment plans.

Radiation oncology coordination for combined modality treatment addresses sequencing, concurrent chemoradiation, and toxicity management. Treatment planning spans both specialties.

Neurosurgery coordination for brain metastases or primary CNS tumors involves surgical and systemic treatment planning.

Pulmonology coordination for lung cancer addresses both oncological and pulmonary management.

Gastroenterology coordination for GI malignancies involves endoscopic procedures and medical management.

Palliative care coordination addresses symptom management, goals of care, and transition to hospice when appropriate.

Supportive services including nutrition, social work, and psychology address comprehensive patient needs.

Implementation and ROI

Oncology implementation addresses infusion scheduling, symptom tracking, pre-authorization, and care coordination.

Week one maps infusion scheduling including regimen templates and chair management. Symptom tracking configures for common chemotherapy side effects. Pre-authorization workflow establishes for cancer therapies.

Week two trains scheduling staff on infusion coordination. Clinical staff trains on patient flow and symptom monitoring. Providers train on dashboard and secure messaging for symptom intervention.

Week three goes live with scheduling, symptom tracking, and pre-authorization.

ROI sources include infusion scheduling efficiency maximizing chair utilization. Early symptom intervention reducing hospitalizations. Pre-authorization efficiency avoiding treatment delays. Better coordination improving patient experience.

Professional tier at $499 monthly includes patient flow, scheduling, pre-authorization, telehealth, secure messaging, and analytics.

Infusionscheduling optimization
Symptomearly intervention
Multi-specialtycoordination
Infusion scheduling optimization increased our chair utilization significantly. Symptom tracking between treatments catches febrile neutropenia early. Prior authorization tracking prevents treatment delays. The coordination with surgery and radiation finally works the way cancer care should.
Practice AdministratorMedical oncology practice

What Oncology practices ask.

See Oncology Operations Optimized

Fifteen-minute demo showing infusion scheduling, symptom tracking, and multi-specialty cancer care coordination.